Triple
T22457477
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH Rules of Procedure |
E555152
|
entity |
| Predicate | appliesTo |
P1129
|
FINISHED |
| Object | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use | Statement: [ICH Rules of Procedure, appliesTo, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Context triple: [ICH Rules of Procedure, appliesTo, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
-
A.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
chosen
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
B.
International Federation of Pharmaceutical Manufacturers & Associations
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global industry body representing research-based biopharmaceutical companies and national associations, advocating for policies that support innovation and access to medicines worldwide.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
Pharmaceutical Inspection Co-operation Scheme
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is an international organization that harmonizes Good Manufacturing Practice (GMP) standards and facilitates cooperation among pharmaceutical regulatory authorities worldwide to ensure the quality and safety of medicines.
-
E.
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7d00208190955a70e2c22d25a4 |
completed | April 29, 2026, 1:14 a.m. |
Created at: April 16, 2026, 8:48 p.m.